"BRAF mutations" trang 1 - tải miễn phí từ tailieunhanh
Complete clinical regression of a BRAF V600Emutant pediatric glioblastoma multiforme after BRAF inhibitor therapy

Complete clinical regression of a BRAF V600Emutant pediatric glioblastoma multiforme after BRAF inhibitor therapy
5    54    1
Improvement of the quality of BRAF testing in melanomas with nationwide external quality assessment, for the BRAF EQA group

Improvement of the quality of BRAF testing in melanomas with nationwide external quality assessment, for the BRAF EQA group
6    39    1
Clinical mutational profiling and categorization of BRAF mutations in melanomas using next generation sequencing

Clinical mutational profiling and categorization of BRAF mutations in melanomas using next generation sequencing
10    80    0
Context-dependent interpretation of the prognostic value of BRAF and KRAS mutations in colorectal cancer

Context-dependent interpretation of the prognostic value of BRAF and KRAS mutations in colorectal cancer
7    66    1
BRAF gene mutations in synchronous papillary thyroid carcinoma and Langerhans cell histiocytosis co-existing in the thyroid gland: A case report and literature review

BRAF gene mutations in synchronous papillary thyroid carcinoma and Langerhans cell histiocytosis co-existing in the thyroid gland: A case report and literature review
6    66    1
Báo cáo hóa học:

Báo cáo hóa học: " Incidence of the V600K mutation among melanoma patients with BRAF mutations, and potential therapeutic response to the specific BRAF inhibitor PLX4032"
3    51    0
Prognostic significance of BRAF and NRAS mutations in melanoma: A German study from routine care

Prognostic significance of BRAF and NRAS mutations in melanoma: A German study from routine care
12    39    1
Variations of BRAF mutant allele percentage in melanomas

Variations of BRAF mutant allele percentage in melanomas
10    30    1
Comparison of high resolution melting analysis, pyrosequencing, next generation sequencing and immunohistochemistry to conventional Sanger sequencing for the detection of p.V600E and non-p.V600E BRAF mutations

Comparison of high resolution melting analysis, pyrosequencing, next generation sequencing and immunohistochemistry to conventional Sanger sequencing for the detection of p.V600E and non-p.V600E BRAF mutations
13    55    1
The clinical response to vemurafenib in a patient with a rare BRAFV600DK601 del mutation-positive melanoma

The clinical response to vemurafenib in a patient with a rare BRAFV600DK601 del mutation-positive melanoma
8    82    1
Effect of dabrafenib on melanoma cell lines harbouring the BRAFV600D/R mutations

Effect of dabrafenib on melanoma cell lines harbouring the BRAFV600D/R mutations
3    40    1
Effect of antiangiogenic-based treatment and systemic inflammatory factors on outcomes in patients with BRAF v600- mutated metastatic colorectal cancer: A real-world study in Spain

Effect of antiangiogenic-based treatment and systemic inflammatory factors on outcomes in patients with BRAF v600- mutated metastatic colorectal cancer: A real-world study in Spain
10    37    1
Impact of KRAS, BRAF and PI3KCA mutations in rectal carcinomas treated with neoadjuvant radiochemotherapy and surgery

Impact of KRAS, BRAF and PI3KCA mutations in rectal carcinomas treated with neoadjuvant radiochemotherapy and surgery
6    54    1
Prevalence and patterns of mutations in RAS/RAF/MEK/ERK/MAPK signaling pathway in colorectal cancer in North Africa

Prevalence and patterns of mutations in RAS/RAF/MEK/ERK/MAPK signaling pathway in colorectal cancer in North Africa
14    8    1
A retrospective observational study of clinicopathological features of KRAS, NRAS, BRAF and PIK3CA mutations in Japanese patients with metastatic colorectal cancer

A retrospective observational study of clinicopathological features of KRAS, NRAS, BRAF and PIK3CA mutations in Japanese patients with metastatic colorectal cancer
9    25    1
Microsatellite instability and mutations in BRAF and KRAS are significant predictors of disseminated disease in colon cancer

Microsatellite instability and mutations in BRAF and KRAS are significant predictors of disseminated disease in colon cancer
11    38    1
Colorectal carcinomas with mucinous differentiation are associated with high frequent mutation of KRAS or BRAF mutations, irrespective of quantity of mucinous component

Colorectal carcinomas with mucinous differentiation are associated with high frequent mutation of KRAS or BRAF mutations, irrespective of quantity of mucinous component
7    51    0
Technical advance in targeted NGS analysis enables identification of lung cancer riskassociated low frequency TP53, PIK3CA, and BRAF mutations in airway epithelial cells

Technical advance in targeted NGS analysis enables identification of lung cancer riskassociated low frequency TP53, PIK3CA, and BRAF mutations in airway epithelial cells
14    96    0
Retrospective study of RAS/PIK3CA/BRAF tumor mutations as predictors of response to first-line chemotherapy with bevacizumab in metastatic colorectal cancer patients

Retrospective study of RAS/PIK3CA/BRAF tumor mutations as predictors of response to first-line chemotherapy with bevacizumab in metastatic colorectal cancer patients
9    50    1
MiRNA profiling, detection of BRAF V600E mutation and RET-PTC1 translocation in patients from Novosibirsk oblast (Russia) with different types of thyroid tumors

MiRNA profiling, detection of BRAF V600E mutation and RET-PTC1 translocation in patients from Novosibirsk oblast (Russia) with different types of thyroid tumors
15    43    1